Cargando…
Overexpression of Rhophilin Rho GTPase-binding protein 2 promotes hepatocellular carcinoma
Hepatocellular carcinoma is a serious public health problem in China. The mortality rate associated with the majority of cancer types has decreased as a result of targeted therapy. However, the mortality rates associated with hepatocellular carcinoma have not improved; therefore, the identification...
Autores principales: | Yuan, Bo, Bo, Wentao, Feng, Xielin, Hu, Yong, Zeng, Jiawei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608026/ https://www.ncbi.nlm.nih.gov/pubmed/33154780 http://dx.doi.org/10.3892/ol.2020.12245 |
Ejemplares similares
-
Overexpression of rhophilin 2 promotes pancreatic ductal adenocarcinoma
por: Bo, Wentao, et al.
Publicado: (2021) -
RHO GTPase family in hepatocellular carcinoma
por: Wang, Tiantian, et al.
Publicado: (2022) -
Rhophilin rho GTPase binding protein 1-antisense RNA 1 (RHPN1-AS1) promotes ovarian carcinogenesis by sponging microRNA-485-5p and releasing DNA topoisomerase II alpha (TOP2A)
por: Zhou, Yi, et al.
Publicado: (2021) -
Integrin α9 Suppresses Hepatocellular Carcinoma Metastasis by Rho GTPase Signaling
por: Zhang, Yan-Li, et al.
Publicado: (2018) -
Fibrosis-4 Model Influences Results of Patients with Hepatocellular Carcinoma Undergoing Hepatectomy
por: Wang, Haiqing, et al.
Publicado: (2018)